搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
2 天
辉瑞财报前瞻:肿瘤药物成潜力股,2024年业绩或超预期!
辉瑞公司 (PFE.US)即将在周二盘前发布令人期待的第四季度财报。分析师们对其表现充满信心,预计每股收益将达到0.46美元,同比激增360.0%,而营收则有望达到172.6亿美元,同比增长21.1%。此次财报的重要性在于,投资者将密切关注辉瑞在肿瘤领域及专业护理产品的前瞻性评论。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Judge pauses buyout offer
Trump bans trans athletes
Blake Lively sued again
Panama denies US claim
Security detail revoked
US deports Indian migrants
Johnson agrees to testify
MX troops arrive at border
Faces primary challenge
Pro-Trump group renamed
Named the new Aga Khan
Trump cases review ordered
Disbands cadet clubs
Newsom meets with Trump
Record producer Gotti dies
Ends DEI hiring goals
DOJ restricts DOGE's access
To split into 3 companies
To boycott G20 meeting
First embryo using IVF
DOJ sues Illinois, Chicago
Hottest January on record
Weekly jobless claims rise
Exit plan for Palestinians
Winter storm hits Northeast
2nd OH shooting victim dies
Workers go on strike
Reaches tentative deal
Second strain in dairy cattle
Parked Delta plane struck
反馈